NO20076411L - Nye organiske forbindelser og fremgangsmate for a fremstille radioaktive halogenmerkede organiske forbindelser anvendende samme - Google Patents

Nye organiske forbindelser og fremgangsmate for a fremstille radioaktive halogenmerkede organiske forbindelser anvendende samme

Info

Publication number
NO20076411L
NO20076411L NO20076411A NO20076411A NO20076411L NO 20076411 L NO20076411 L NO 20076411L NO 20076411 A NO20076411 A NO 20076411A NO 20076411 A NO20076411 A NO 20076411A NO 20076411 L NO20076411 L NO 20076411L
Authority
NO
Norway
Prior art keywords
organic compounds
radioactive halogen
methods
same
amino
Prior art date
Application number
NO20076411A
Other languages
English (en)
Inventor
Masahito Toyama
Fumie Kurosaki
Akio Hayashi
Osamu Ito
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of NO20076411L publication Critical patent/NO20076411L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen tilveiebringer en merkingsforløperforbindelse anvendt for selektivt å fremstille radioaktive halogensubstituerte syn-l-amino-3-cyklobutan-karboksylsyrer og å tilveiebringe en prosess for fremstilling av en radioaktivt halogensubstituert syn-l-amino-3-cyklobutan-karboksylsyre ved bruk av merkingsforløperforbindelsen. En merkingsforløper anvendes hvori ftalimidgruppen anvendes som en beskyttende gruppe for å beskytte aminogruppen. Syn-formen av den radioaktivt halogensubstituerte l-amino-3-cyklobutan-karboksylsyre kan selektivt fremstilles ved merking av merkingsforløperen med et radioaktivt halogen etterfulgt av avbeskyttelse.
NO20076411A 2005-05-23 2007-12-12 Nye organiske forbindelser og fremgangsmate for a fremstille radioaktive halogenmerkede organiske forbindelser anvendende samme NO20076411L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005149186 2005-05-23
PCT/JP2006/309643 WO2006126410A1 (ja) 2005-05-23 2006-05-15 新規有機化合物及び該化合物を利用した放射性ハロゲン標識有機化合物の製造方法

Publications (1)

Publication Number Publication Date
NO20076411L true NO20076411L (no) 2008-02-13

Family

ID=37451836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076411A NO20076411L (no) 2005-05-23 2007-12-12 Nye organiske forbindelser og fremgangsmate for a fremstille radioaktive halogenmerkede organiske forbindelser anvendende samme

Country Status (15)

Country Link
US (1) US7910745B2 (no)
EP (1) EP1889834B1 (no)
JP (1) JP4989467B2 (no)
KR (1) KR101315152B1 (no)
CN (1) CN101180272B (no)
AT (1) ATE506347T1 (no)
AU (1) AU2006250594B2 (no)
CA (1) CA2608919C (no)
DE (1) DE602006021418D1 (no)
DK (1) DK1889834T3 (no)
ES (1) ES2364463T3 (no)
HK (1) HK1117529A1 (no)
NO (1) NO20076411L (no)
TW (1) TWI410396B (no)
WO (1) WO2006126410A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007001958A2 (en) * 2005-06-23 2007-01-04 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
KR101643991B1 (ko) 2005-11-29 2016-07-29 니혼 메디피직스 가부시키가이샤 방사성 할로겐 표식 유기 화합물의 전구체 화합물
CN101563107B (zh) 2006-12-21 2012-07-11 日本医事物理股份有限公司 放射性诊断显像剂
EP2128130B1 (en) * 2006-12-27 2018-10-10 Nihon Medi-Physics Co., Ltd. Process for production of precursor compound for radioactive halogen-labeled organic compound
TWI406674B (zh) * 2007-02-13 2013-09-01 Nihon Mediphysics Co Ltd Method for manufacturing diagnostic radiographic diagnostic agents
JP5121349B2 (ja) * 2007-08-10 2013-01-16 株式会社トクヤマ アミノ酸の製造方法
KR20120034098A (ko) * 2009-07-11 2012-04-09 바이엘 파마 악티엔게젤샤프트 시클로알킬 기를 사용하는 방사성 표지 방법
JP2014501702A (ja) 2010-10-28 2014-01-23 ジーイー・ヘルスケア・リミテッド 放射性医薬品前駆体の安定化
GB201305687D0 (en) * 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
JP7159157B2 (ja) * 2017-06-23 2022-10-24 日本メジフィジックス株式会社 放射性フッ素標識化合物の製造方法および放射性医薬の製造方法
CN110724058A (zh) * 2019-10-25 2020-01-24 吉林凯莱英制药有限公司 反式环丁烷邻二羧酸酯及其衍生物的制备方法
WO2021077424A1 (zh) * 2019-10-25 2021-04-29 吉林凯莱英制药有限公司 反式环丁烷邻二羧酸酯及其衍生物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808146A (en) 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
FR2841554B1 (fr) * 2002-07-01 2008-01-18 Commissariat Energie Atomique Composes de maleimides marques, leur procede de preparation et leur utilisation pour le marquage de macromolecules
GB0229695D0 (en) 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids

Also Published As

Publication number Publication date
TWI410396B (zh) 2013-10-01
DK1889834T3 (da) 2011-08-08
EP1889834A1 (en) 2008-02-20
JP4989467B2 (ja) 2012-08-01
KR20080016557A (ko) 2008-02-21
JPWO2006126410A1 (ja) 2008-12-25
KR101315152B1 (ko) 2013-10-07
ES2364463T3 (es) 2011-09-02
US7910745B2 (en) 2011-03-22
CN101180272A (zh) 2008-05-14
AU2006250594B2 (en) 2011-06-16
TW200704630A (en) 2007-02-01
AU2006250594A1 (en) 2006-11-30
DE602006021418D1 (de) 2011-06-01
EP1889834B1 (en) 2011-04-20
WO2006126410A1 (ja) 2006-11-30
CA2608919A1 (en) 2006-11-30
HK1117529A1 (en) 2009-01-16
CN101180272B (zh) 2012-04-25
EP1889834A4 (en) 2010-06-30
CA2608919C (en) 2012-11-20
ATE506347T1 (de) 2011-05-15
US20090105489A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
NO20076411L (no) Nye organiske forbindelser og fremgangsmate for a fremstille radioaktive halogenmerkede organiske forbindelser anvendende samme
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
ATE550319T1 (de) Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats
CY1118310T1 (el) Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξυαμιδο-πυριδινο βενζοϊκων οξεων
TW200738271A (en) Methods of making radiolabeled tracers and precursors thereof
AR098260A2 (es) Polimorfo cristalino de una sal de bisulfato de un antagonista del receptor de trombina, proceso para su preparación, composición y forma purificada
BRPI0512987A (pt) processo para preparar compostos, composto, uso do mesmo, e, material de revestimento termicamente curável, curável por radiação ou de cura dupla
ATE487702T1 (de) Verfahren zum herstellen von 3-dihalomethyl- pyrazol-4-carbonsäurederivaten
ATE550312T1 (de) Verfahren zur herstellung von 3,3,3- trifluorpropyn
TW200634430A (en) Photosensitive composition, compound for use in the photosensitive composition and pattern forming method using the photosensitive composition
AR059916A1 (es) Procesos y productos intermedios para preparar compuestos esterico
CY1108491T1 (el) Μεθοδος παρασκευης οπτικως ενεργων παραγωγων του 2-(2-πυριδυλομεθυλοσουλφινυλο)-βενζιμιδαζολιου μεσω συμπλοκου εγκλεισμου με την 1,1'-διναφθαλινο-2,2'-διολη
ATE519832T1 (de) Verfahren zum erhalt von lipid aus zellen
GEP20135926B (en) Trazodone and trazodone hydrochloride in purified form
TW201129535A (en) Alcoholic hydroxyl-containing compounds and making method
BRPI0519886A2 (pt) processo para produção de energia e aparelho para realizar o mesmo
ES2634683T3 (es) Método de preparación de cisteína o de un derivado de la misma utilizando una nueva O-fosfoserina sulfhidrilasa
WO2010120058A3 (ko) 생체 분자 표지를 위한 신규 시아닌 화합물 및 그 제조방법
IL187640A0 (en) Method for preparing clopidogrel and intermediates used therein
MY146360A (en) Process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof
UY29498A1 (es) Derivados de aminoácidos
ATE533086T1 (de) Lichtempfindliche zusammensetzung und verfahren zur strukturformung damit
MX2010005015A (es) Metodos para preparar capecitabina y un compuesto de carbonato trialquilo rico en beta-anomero.
ATE538102T1 (de) Verfahren zur herstellung eines chinazolinderivats
ATE365739T1 (de) Verfahren zur herstellung optisch aktiver 3- chinuclidinole

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application